Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Robotic Surgical Procedures | 56 | 2023 | 261 | 25.730 |
Why?
|
Coronary Artery Disease | 26 | 2023 | 333 | 12.200 |
Why?
|
Coronary Artery Bypass | 39 | 2023 | 219 | 11.970 |
Why?
|
Endoscopy | 35 | 2023 | 322 | 11.500 |
Why?
|
Coronary Artery Bypass, Off-Pump | 14 | 2022 | 35 | 8.280 |
Why?
|
Cardiac Surgical Procedures | 18 | 2023 | 454 | 7.580 |
Why?
|
Robotics | 14 | 2022 | 265 | 5.530 |
Why?
|
Mammary Arteries | 11 | 2023 | 30 | 5.090 |
Why?
|
Coronary Vessels | 7 | 2020 | 170 | 3.820 |
Why?
|
Percutaneous Coronary Intervention | 5 | 2020 | 56 | 3.460 |
Why?
|
Minimally Invasive Surgical Procedures | 17 | 2023 | 225 | 3.270 |
Why?
|
Heart Valve Prosthesis Implantation | 6 | 2021 | 153 | 2.780 |
Why?
|
Mitral Valve Insufficiency | 7 | 2022 | 185 | 2.530 |
Why?
|
Aortic Valve | 7 | 2022 | 206 | 2.270 |
Why?
|
Treatment Outcome | 34 | 2023 | 7776 | 2.250 |
Why?
|
Vascular Patency | 9 | 2023 | 123 | 1.930 |
Why?
|
Anastomosis, Surgical | 7 | 2021 | 284 | 1.790 |
Why?
|
Retrospective Studies | 28 | 2023 | 8061 | 1.740 |
Why?
|
Humans | 92 | 2023 | 83873 | 1.690 |
Why?
|
Aorta | 3 | 2023 | 274 | 1.550 |
Why?
|
Heart Neoplasms | 3 | 2019 | 61 | 1.540 |
Why?
|
Coronary Angiography | 9 | 2023 | 217 | 1.510 |
Why?
|
Aged | 37 | 2022 | 18098 | 1.470 |
Why?
|
Mitral Valve | 9 | 2023 | 244 | 1.410 |
Why?
|
Pericardiectomy | 4 | 2020 | 9 | 1.250 |
Why?
|
Middle Aged | 38 | 2022 | 24691 | 1.240 |
Why?
|
Male | 46 | 2021 | 40239 | 1.160 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2023 | 41 | 1.110 |
Why?
|
Obesity, Morbid | 2 | 2018 | 217 | 1.070 |
Why?
|
Length of Stay | 10 | 2020 | 684 | 1.050 |
Why?
|
Carbapenems | 2 | 2016 | 9 | 1.040 |
Why?
|
Acinetobacter Infections | 2 | 2016 | 14 | 1.040 |
Why?
|
Myocardial Revascularization | 3 | 2021 | 31 | 1.040 |
Why?
|
beta-Lactam Resistance | 2 | 2016 | 11 | 1.040 |
Why?
|
Thoracic Surgery | 2 | 2021 | 41 | 1.000 |
Why?
|
Aortic Valve Stenosis | 3 | 2021 | 121 | 0.970 |
Why?
|
Female | 37 | 2021 | 43741 | 0.910 |
Why?
|
Atrial Fibrillation | 4 | 2020 | 265 | 0.900 |
Why?
|
Fibroma | 2 | 2019 | 32 | 0.890 |
Why?
|
Pulmonary Veins | 2 | 2020 | 67 | 0.880 |
Why?
|
Heart Valve Diseases | 2 | 2019 | 99 | 0.860 |
Why?
|
Reoperation | 3 | 2019 | 587 | 0.860 |
Why?
|
One-Lung Ventilation | 2 | 2020 | 4 | 0.850 |
Why?
|
Aged, 80 and over | 16 | 2019 | 6453 | 0.830 |
Why?
|
Scimitar Syndrome | 1 | 2020 | 3 | 0.800 |
Why?
|
Cross Infection | 2 | 2012 | 137 | 0.790 |
Why?
|
Anti-Bacterial Agents | 3 | 2016 | 702 | 0.790 |
Why?
|
Vena Cava, Superior | 1 | 2020 | 59 | 0.770 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2020 | 66 | 0.750 |
Why?
|
Mortality | 2 | 2018 | 148 | 0.740 |
Why?
|
Pericarditis | 1 | 2019 | 13 | 0.740 |
Why?
|
Analgesia | 2 | 2021 | 58 | 0.740 |
Why?
|
Sutureless Surgical Procedures | 1 | 2019 | 6 | 0.720 |
Why?
|
Physician Assistants | 1 | 2019 | 18 | 0.720 |
Why?
|
Mitral Valve Stenosis | 1 | 2019 | 37 | 0.720 |
Why?
|
Angioplasty, Balloon | 1 | 2019 | 94 | 0.710 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 111 | 0.700 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2020 | 101 | 0.690 |
Why?
|
Operative Time | 4 | 2019 | 125 | 0.690 |
Why?
|
Blood Transfusion | 1 | 2019 | 152 | 0.680 |
Why?
|
Tertiary Care Centers | 3 | 2016 | 93 | 0.680 |
Why?
|
Surgery, Computer-Assisted | 2 | 2018 | 98 | 0.670 |
Why?
|
Aortic Valve Insufficiency | 1 | 2019 | 125 | 0.660 |
Why?
|
Endovascular Procedures | 1 | 2020 | 202 | 0.640 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.620 |
Why?
|
Suture Techniques | 1 | 2018 | 138 | 0.620 |
Why?
|
Cardiopulmonary Bypass | 4 | 2020 | 143 | 0.600 |
Why?
|
Acinetobacter baumannii | 1 | 2016 | 22 | 0.590 |
Why?
|
Blood Vessel Prosthesis | 1 | 2018 | 221 | 0.590 |
Why?
|
Heart Ventricles | 2 | 2019 | 747 | 0.580 |
Why?
|
Equipment Design | 5 | 2018 | 404 | 0.580 |
Why?
|
Hemorrhage | 1 | 2018 | 247 | 0.580 |
Why?
|
Postoperative Complications | 5 | 2018 | 2195 | 0.580 |
Why?
|
beta-Lactamases | 1 | 2016 | 50 | 0.570 |
Why?
|
Catheter Ablation | 2 | 2016 | 222 | 0.570 |
Why?
|
Transcatheter Aortic Valve Replacement | 3 | 2022 | 43 | 0.570 |
Why?
|
Bupivacaine | 1 | 2015 | 45 | 0.560 |
Why?
|
Laparoscopy | 1 | 2022 | 740 | 0.540 |
Why?
|
Anesthetics, Local | 1 | 2015 | 79 | 0.540 |
Why?
|
Heart Diseases | 1 | 2017 | 287 | 0.530 |
Why?
|
Follow-Up Studies | 6 | 2020 | 3603 | 0.520 |
Why?
|
Pain Management | 1 | 2015 | 126 | 0.510 |
Why?
|
Risk Factors | 8 | 2021 | 5301 | 0.480 |
Why?
|
Heart Arrest, Induced | 2 | 2022 | 29 | 0.460 |
Why?
|
Acinetobacter | 1 | 2012 | 4 | 0.450 |
Why?
|
Klebsiella Infections | 1 | 2012 | 24 | 0.430 |
Why?
|
Klebsiella pneumoniae | 1 | 2012 | 34 | 0.430 |
Why?
|
Disease Outbreaks | 1 | 2012 | 163 | 0.400 |
Why?
|
Adult | 12 | 2021 | 25203 | 0.400 |
Why?
|
Heart | 3 | 2023 | 523 | 0.390 |
Why?
|
Heart Valve Prosthesis | 2 | 2022 | 89 | 0.380 |
Why?
|
Coronary Disease | 1 | 2011 | 260 | 0.380 |
Why?
|
Saudi Arabia | 3 | 2016 | 16 | 0.370 |
Why?
|
Tricuspid Valve | 2 | 2020 | 86 | 0.370 |
Why?
|
Postoperative Period | 3 | 2019 | 305 | 0.360 |
Why?
|
Perioperative Period | 2 | 2019 | 26 | 0.350 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2020 | 65 | 0.350 |
Why?
|
Heart Atria | 2 | 2016 | 236 | 0.350 |
Why?
|
Computed Tomography Angiography | 2 | 2020 | 118 | 0.340 |
Why?
|
Heart Failure | 1 | 2018 | 1153 | 0.340 |
Why?
|
Echocardiography, Transesophageal | 4 | 2020 | 341 | 0.330 |
Why?
|
Pericardium | 2 | 2019 | 63 | 0.320 |
Why?
|
Peripheral Vascular Diseases | 2 | 2018 | 61 | 0.320 |
Why?
|
Prosthesis Design | 2 | 2019 | 270 | 0.320 |
Why?
|
Stroke Volume | 2 | 2022 | 431 | 0.320 |
Why?
|
Arrhythmias, Cardiac | 2 | 2020 | 184 | 0.320 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2017 | 653 | 0.300 |
Why?
|
Surgeons | 2 | 2021 | 213 | 0.300 |
Why?
|
Feasibility Studies | 2 | 2019 | 741 | 0.300 |
Why?
|
Echocardiography, Three-Dimensional | 3 | 2017 | 506 | 0.300 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 577 | 0.290 |
Why?
|
Hemodynamics | 2 | 2020 | 697 | 0.290 |
Why?
|
Myocardial Infarction | 2 | 2019 | 352 | 0.280 |
Why?
|
Heart Transplantation | 2 | 2023 | 681 | 0.280 |
Why?
|
Chordae Tendineae | 2 | 2015 | 23 | 0.270 |
Why?
|
Combined Modality Therapy | 3 | 2018 | 1645 | 0.260 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 397 | 0.260 |
Why?
|
Graft Occlusion, Vascular | 2 | 2019 | 98 | 0.260 |
Why?
|
Endoscopes | 1 | 2004 | 9 | 0.250 |
Why?
|
Microbial Sensitivity Tests | 2 | 2016 | 136 | 0.250 |
Why?
|
Surgical Stapling | 1 | 2004 | 18 | 0.250 |
Why?
|
Microwaves | 1 | 2004 | 28 | 0.250 |
Why?
|
Hospital Mortality | 2 | 2019 | 342 | 0.240 |
Why?
|
Cluster Analysis | 2 | 2016 | 362 | 0.240 |
Why?
|
Patient Positioning | 2 | 2020 | 65 | 0.230 |
Why?
|
Sternum | 1 | 2022 | 27 | 0.230 |
Why?
|
Thoracotomy | 1 | 2022 | 57 | 0.220 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 797 | 0.220 |
Why?
|
Time Factors | 3 | 2019 | 5176 | 0.210 |
Why?
|
Prognosis | 2 | 2019 | 3618 | 0.210 |
Why?
|
Colombia | 1 | 2020 | 11 | 0.200 |
Why?
|
Pulmonary Edema | 1 | 2021 | 50 | 0.200 |
Why?
|
Morphine | 1 | 2021 | 129 | 0.200 |
Why?
|
Survival Analysis | 2 | 2017 | 1531 | 0.200 |
Why?
|
Myocardial Bridging | 1 | 2020 | 2 | 0.200 |
Why?
|
Lead Poisoning | 1 | 2020 | 9 | 0.200 |
Why?
|
Patient Discharge | 1 | 2023 | 280 | 0.190 |
Why?
|
Nobel Prize | 1 | 2020 | 10 | 0.190 |
Why?
|
Mitral Valve Prolapse | 1 | 2020 | 22 | 0.190 |
Why?
|
Prevalence | 3 | 2023 | 1218 | 0.190 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 60 | 0.190 |
Why?
|
Simulation Training | 1 | 2021 | 88 | 0.190 |
Why?
|
Epicardial Mapping | 1 | 2019 | 10 | 0.190 |
Why?
|
Career Choice | 1 | 2021 | 138 | 0.190 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2019 | 18 | 0.190 |
Why?
|
Multidetector Computed Tomography | 1 | 2020 | 52 | 0.190 |
Why?
|
Pain | 1 | 2022 | 383 | 0.180 |
Why?
|
Young Adult | 3 | 2017 | 5843 | 0.180 |
Why?
|
Inservice Training | 1 | 2019 | 38 | 0.180 |
Why?
|
History, 21st Century | 1 | 2020 | 175 | 0.180 |
Why?
|
Genotype | 2 | 2016 | 1831 | 0.180 |
Why?
|
Coronary Occlusion | 1 | 2019 | 8 | 0.180 |
Why?
|
Bioprosthesis | 1 | 2019 | 36 | 0.180 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2021 | 136 | 0.180 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2019 | 65 | 0.170 |
Why?
|
Medicare | 1 | 2022 | 364 | 0.170 |
Why?
|
Safety | 1 | 2019 | 152 | 0.170 |
Why?
|
History, 20th Century | 1 | 2020 | 312 | 0.170 |
Why?
|
Retreatment | 1 | 2018 | 107 | 0.170 |
Why?
|
Vascular Calcification | 1 | 2019 | 38 | 0.170 |
Why?
|
Interactive Ventilatory Support | 1 | 2018 | 5 | 0.170 |
Why?
|
Surgical Staplers | 1 | 2018 | 11 | 0.170 |
Why?
|
Recovery of Function | 1 | 2019 | 271 | 0.160 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2017 | 16 | 0.160 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 129 | 0.160 |
Why?
|
Gender Identity | 1 | 2018 | 46 | 0.160 |
Why?
|
Radial Artery | 1 | 2017 | 25 | 0.160 |
Why?
|
Saphenous Vein | 1 | 2017 | 59 | 0.160 |
Why?
|
Morbidity | 1 | 2018 | 144 | 0.160 |
Why?
|
Acute Disease | 1 | 2019 | 811 | 0.160 |
Why?
|
Child, Preschool | 2 | 2016 | 3569 | 0.160 |
Why?
|
Renal Insufficiency | 1 | 2018 | 110 | 0.160 |
Why?
|
Echocardiography | 2 | 2019 | 893 | 0.150 |
Why?
|
Severity of Illness Index | 2 | 2020 | 1753 | 0.150 |
Why?
|
Risk | 1 | 2018 | 671 | 0.150 |
Why?
|
Cardiomyopathies | 1 | 2019 | 233 | 0.150 |
Why?
|
Tissue and Organ Harvesting | 1 | 2017 | 77 | 0.150 |
Why?
|
Prospective Studies | 2 | 2018 | 4090 | 0.150 |
Why?
|
Multilocus Sequence Typing | 1 | 2016 | 11 | 0.150 |
Why?
|
Atrial Septum | 1 | 2016 | 9 | 0.150 |
Why?
|
Overweight | 1 | 2017 | 115 | 0.150 |
Why?
|
Pericarditis, Constrictive | 1 | 2016 | 5 | 0.150 |
Why?
|
Molecular Epidemiology | 1 | 2016 | 52 | 0.150 |
Why?
|
Coronary Sinus | 1 | 2016 | 6 | 0.150 |
Why?
|
Recurrence | 1 | 2019 | 1136 | 0.150 |
Why?
|
Quality Improvement | 1 | 2020 | 408 | 0.150 |
Why?
|
Ventricular Fibrillation | 1 | 2016 | 65 | 0.140 |
Why?
|
Heart Conduction System | 1 | 2016 | 106 | 0.140 |
Why?
|
Plasmids | 1 | 2016 | 279 | 0.140 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2016 | 87 | 0.140 |
Why?
|
Liposomes | 1 | 2015 | 92 | 0.140 |
Why?
|
DNA, Bacterial | 1 | 2016 | 230 | 0.140 |
Why?
|
Anatomic Landmarks | 1 | 2015 | 33 | 0.140 |
Why?
|
Hypertonic Solutions | 1 | 1995 | 17 | 0.140 |
Why?
|
Tachycardia, Ventricular | 1 | 2016 | 112 | 0.140 |
Why?
|
Organ Preservation Solutions | 1 | 1995 | 27 | 0.140 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2015 | 62 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2016 | 86 | 0.140 |
Why?
|
Therapeutics | 1 | 2014 | 12 | 0.130 |
Why?
|
Organ Preservation | 1 | 1995 | 75 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 2497 | 0.130 |
Why?
|
Multimodal Imaging | 1 | 2015 | 106 | 0.130 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 344 | 0.130 |
Why?
|
Intraoperative Complications | 1 | 2016 | 183 | 0.130 |
Why?
|
Body Mass Index | 1 | 2018 | 764 | 0.130 |
Why?
|
Device Removal | 1 | 2016 | 158 | 0.130 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 921 | 0.130 |
Why?
|
Comorbidity | 1 | 2017 | 933 | 0.120 |
Why?
|
Quality of Life | 1 | 2021 | 1504 | 0.120 |
Why?
|
Pulmonary Artery | 1 | 1995 | 293 | 0.120 |
Why?
|
Child | 2 | 2016 | 6706 | 0.120 |
Why?
|
Ischemia | 1 | 1995 | 238 | 0.120 |
Why?
|
Coronary Stenosis | 1 | 2013 | 39 | 0.120 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 835 | 0.120 |
Why?
|
Case-Control Studies | 1 | 2017 | 1786 | 0.120 |
Why?
|
Heart Arrest | 1 | 2016 | 262 | 0.120 |
Why?
|
Software | 1 | 2017 | 646 | 0.110 |
Why?
|
Internship and Residency | 1 | 2021 | 977 | 0.110 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 19 | 0.110 |
Why?
|
Molecular Typing | 1 | 2012 | 17 | 0.110 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2012 | 43 | 0.110 |
Why?
|
Wisconsin | 1 | 2011 | 38 | 0.110 |
Why?
|
Adolescent | 2 | 2016 | 8806 | 0.110 |
Why?
|
Heart-Assist Devices | 1 | 2019 | 716 | 0.100 |
Why?
|
Cohort Studies | 2 | 2012 | 2703 | 0.100 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2012 | 99 | 0.100 |
Why?
|
Electrocardiography | 3 | 2019 | 472 | 0.100 |
Why?
|
Hypertension | 1 | 2019 | 1114 | 0.100 |
Why?
|
Obesity | 1 | 2017 | 939 | 0.100 |
Why?
|
Infection Control | 1 | 2012 | 114 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2020 | 2652 | 0.100 |
Why?
|
Burns | 1 | 2012 | 124 | 0.100 |
Why?
|
Algorithms | 2 | 2017 | 1803 | 0.100 |
Why?
|
Odds Ratio | 1 | 2012 | 670 | 0.090 |
Why?
|
Survival Rate | 2 | 2011 | 1843 | 0.090 |
Why?
|
Stroke | 1 | 2018 | 888 | 0.090 |
Why?
|
Lung | 1 | 1995 | 1124 | 0.090 |
Why?
|
Angiography | 1 | 2009 | 202 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2012 | 359 | 0.090 |
Why?
|
Myocardial Ischemia | 1 | 2009 | 154 | 0.080 |
Why?
|
Image Enhancement | 3 | 2017 | 559 | 0.080 |
Why?
|
Risk Assessment | 3 | 2021 | 2223 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 1967 | 0.080 |
Why?
|
Hospitalization | 1 | 2012 | 809 | 0.070 |
Why?
|
Infant | 1 | 2012 | 2993 | 0.070 |
Why?
|
Clinical Competence | 2 | 2021 | 746 | 0.070 |
Why?
|
Disease Progression | 1 | 2009 | 1478 | 0.070 |
Why?
|
Equipment Failure Analysis | 1 | 2004 | 90 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2023 | 110 | 0.060 |
Why?
|
Risk Adjustment | 1 | 2022 | 39 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2021 | 44 | 0.050 |
Why?
|
Decontamination | 1 | 2021 | 9 | 0.050 |
Why?
|
Myocardial Contraction | 1 | 2003 | 242 | 0.050 |
Why?
|
Weights and Measures | 1 | 2020 | 7 | 0.050 |
Why?
|
Contraindications | 1 | 2020 | 70 | 0.050 |
Why?
|
Tissue Donors | 1 | 2023 | 442 | 0.050 |
Why?
|
Perception | 1 | 2021 | 159 | 0.050 |
Why?
|
Hospitals | 1 | 2022 | 264 | 0.050 |
Why?
|
Myocardium | 1 | 2022 | 520 | 0.050 |
Why?
|
Consensus | 1 | 2021 | 309 | 0.040 |
Why?
|
Electrodes, Implanted | 1 | 2019 | 164 | 0.040 |
Why?
|
Non-Randomized Controlled Trials as Topic | 1 | 2017 | 7 | 0.040 |
Why?
|
Prosthesis Fitting | 1 | 2017 | 15 | 0.040 |
Why?
|
Curriculum | 1 | 2021 | 527 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2021 | 1797 | 0.040 |
Why?
|
Sex Factors | 1 | 2020 | 1038 | 0.040 |
Why?
|
Heart Injuries | 1 | 2016 | 15 | 0.040 |
Why?
|
Vascular Surgical Procedures | 1 | 2017 | 147 | 0.040 |
Why?
|
Patient Selection | 1 | 2020 | 680 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 568 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 1996 | 140 | 0.040 |
Why?
|
Carotid Arteries | 1 | 1996 | 126 | 0.040 |
Why?
|
Surgical Wound Infection | 1 | 2017 | 185 | 0.030 |
Why?
|
Thromboxane B2 | 1 | 1995 | 11 | 0.030 |
Why?
|
Raffinose | 1 | 1995 | 23 | 0.030 |
Why?
|
Partial Pressure | 1 | 1995 | 51 | 0.030 |
Why?
|
Chronic Disease | 1 | 2019 | 950 | 0.030 |
Why?
|
Indomethacin | 1 | 1995 | 59 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 1636 | 0.030 |
Why?
|
Reperfusion | 1 | 1995 | 26 | 0.030 |
Why?
|
Vascular Resistance | 1 | 1995 | 98 | 0.030 |
Why?
|
Pandemics | 1 | 2021 | 693 | 0.030 |
Why?
|
Glutathione | 1 | 1995 | 102 | 0.030 |
Why?
|
Allopurinol | 1 | 1995 | 79 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2015 | 103 | 0.030 |
Why?
|
Stomach | 1 | 2015 | 109 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 316 | 0.030 |
Why?
|
Rabbits | 1 | 1995 | 634 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2017 | 457 | 0.030 |
Why?
|
Observer Variation | 1 | 2015 | 594 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 825 | 0.030 |
Why?
|
Adenosine | 1 | 1995 | 218 | 0.030 |
Why?
|
Radiography | 1 | 2013 | 799 | 0.030 |
Why?
|
Preoperative Care | 1 | 2013 | 393 | 0.020 |
Why?
|
Oxygen | 1 | 1995 | 721 | 0.020 |
Why?
|
Insulin | 1 | 1995 | 1150 | 0.020 |
Why?
|
United States | 1 | 2022 | 6425 | 0.020 |
Why?
|
Blood Pressure | 1 | 1995 | 1121 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 1996 | 75 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 1996 | 106 | 0.010 |
Why?
|
Animals | 1 | 1995 | 26005 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1996 | 988 | 0.010 |
Why?
|